Lundbeck Settles Antitrust Suit Over Infant Heart Drugs
Lundbeck Inc. said Monday it had settled a proposed antitrust class action brought by a group of hospitals alleging the company set monopoly prices on drugs used to treat heart defects...To view the full article, register now.
Already a subscriber? Click here to view full article